The FDA’s top vaccine regulator outlines proposed changes to the vaccine evaluation process in an internal memo.
The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual restrictions. Novavax makes the nation’s only traditional protein-based ...
The Food and Drug Administration (FDA) signed off Wednesday on an emergency use authorization for the Novavax COVID-19 vaccine for individuals 18 years of age and older. The Novavax vaccine is ...
There may soon be another COVID-19 vaccine on the market in the U.S. Novavax announced Monday that it has submitted a request to the Food and Drug Administration for emergency use authorization for ...
Announcement, and lack of details in the weeks following, represents major departure from previous FDA priorities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results